Sonnet biotherapeutics to present at the 2023 btig virtual biotechnology conference

Princeton, nj / accesswire / july 31, 2023 / sonnet biotherapeutics holdings, inc. (nasdaq:sonn) ("sonnet" or the "company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that pankaj mohan, phd, founder and chief executive officer, jay cross, chief financial officer, and richard kenney, md, chief medical officer, will be presenting a corporate overview at the btig virtual biotechnology conference, held august 7-8, 2023. sonnet biotherapeutics fireside chat details: 2023 btig virtual biotechnology conferencedate: monday, august 7, 2023presentation time: 12:00 pm et forward-looking statements this press release contains certain forward-looking statements within the meaning of section 27a of the securities act of 1933 and section21e of the securities exchange act of 1934 and private securities litigation reform act, as amended, including those relating to the offering, the closing of the offering, the amount and anticipated use of proceeds from the offering, the timing of an ind submission, the company's product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature.
SONN Ratings Summary
SONN Quant Ranking